Ignacio Faustino is co-founder of the start-up Colonova, a spin-off of the University of Groningen. Colonova is focused on improving people’s quality of life by increasing the efficacy of medicinal products and reducing the side effects associated with treating gastrointestinal diseases. To this end, Colonova develops oral formulations using the ColoPulse technology, a technology platform developed by the laboratory of prof. H.W. Frijlink (Department of Pharmaceutical Technology and Biopharmacy, University of Groningen), that has been clinically proven and can be combined with a wide range of core substances, ranging from small molecules to biologics. Ignacio speaks several languages (English, Italian, Dutch and native Spanish) and is a calm, collected, and very approachable person, open to suggestions, leads by example.